Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001106578-25-000004

Chairperson & CEO sold 8,000 shares at an average $397.97 ($3,183,777)

  • Chairperson & CEO acquired 8,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2025-09-10 Exercise or conversion : show line 1 in the form 10b5-1 +4,000 $120.26 $481,040 4,130 D
2025-09-10 Sale : show line 2 in the form 10b5-1 −2,000 $398.11 $796,220 2,130 D
2025-09-10 Sale : show line 3 in the form 10b5-1 −2,000 $399.33 $798,653 130 D
2025-09-11 Exercise or conversion : show line 4 in the form 10b5-1 +4,000 $120.26 $481,040 4,130 D
2025-09-11 Sale : show line 5 in the form 10b5-1 −4,000 $397.23 $1,588,904 130 D
Open-market sales · 8,000 sh · avg $397.97 · $3,183,777

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2025-09-10 Exercise or conversion : show line 6 in the form 10b5-1 Stock Option −4,000 $120.26 2026-03-15 4,000 282,000 D
2025-09-11 Exercise or conversion : show line 7 in the form 10b5-1 Stock Option −4,000 $120.26 2026-03-15 4,000 278,000 D
Loading xslF345X05/primarydocument.xml…